山東未(wei)名(ming)(ming)(ming)生物醫(yi)藥(yao)股份有限公司(si)(si)（以下簡(jian)(jian)稱“未(wei)名(ming)(ming)(ming)醫(yi)藥(yao)”或“公司(si)(si)”）是未(wei)名(ming)(ming)(ming)集(ji)團控股的在深圳(zhen)證(zheng)券(quan)交易(yi)所上市的A股公眾公司(si)(si)，證(zheng)券(quan)簡(jian)(jian)稱：未(wei)名(ming)(ming)(ming)醫(yi)藥(yao)，證(zheng)券(quan)代(dai)碼(ma)：002581。公司(si)(si)于(yu)2015年10月19日經重大資產重組原“淄(zi)博萬(wan)昌科技股份有(you)限(xian)(xian)公(gong)(gong)司”更名(ming)(ming)而成。公(gong)(gong)司擁有(you)未(wei)(wei)名(ming)(ming)生物(wu)醫(yi)藥(yao)有(you)限(xian)(xian)公(gong)(gong)司（廈門）、天津未(wei)(wei)名(ming)(ming)生物(wu)醫(yi)藥(yao)有(you)限(xian)(xian)公(gong)(gong)司、北(bei)京(jing)科興生物(wu)制(zhi)品有(you)限(xian)(xian)公(gong)(gong)司、山東未(wei)(wei)名(ming)(ming)天源生物(wu)科技有(you)限(xian)(xian)公(gong)(gong)司、北(bei)京(jing)未(wei)(wei)名(ming)(ming)西大(da)生物(wu)科技有(you)限(xian)(xian)公(gong)(gong)司、合肥北(bei)大(da)未(wei)(wei)名(ming)(ming)生物(wu)制(zhi)藥(yao)有(you)限(xian)(xian)公(gong)(gong)司等下(xia)屬企業或生產基地(di)。
未名(ming)集團(tuan)三(san)(san)大夢想之一是“解決中(zhong)國健康問題”：通(tong)(tong)過(guo)(guo)發(fa)展(zhan)生物(wu)醫(yi)藥(yao)(yao)產業(ye)(ye)，建(jian)立(li)(li)健康產品供給(gei)體系(xi)；通(tong)(tong)過(guo)(guo)發(fa)展(zhan)現(xian)代(dai)中(zhong)醫(yi)藥(yao)(yao)，建(jian)立(li)(li)中(zhong)國特(te)色的健康服務體系(xi)；通(tong)(tong)過(guo)(guo)實施(shi)GHP計劃，建(jian)立(li)(li)生命健康管理體系(xi)。未名(ming)醫(yi)藥(yao)(yao)將(jiang)發(fa)展(zhan)藥(yao)(yao)物(wu)制造、新藥(yao)(yao)研發(fa)、產品配送三(san)(san)大系(xi)統，建(jian)成完善的健康產品供給(gei)體系(xi)，通(tong)(tong)過(guo)(guo)實施(shi)“百千(qian)萬億工程”，到(dao)2030年實現(xian)以(yi)下目標：未名(ming)醫(yi)藥(yao)(yao)占中(zhong)國醫(yi)藥(yao)(yao)市場(chang)總銷售(shou)額的10%、占生物(wu)醫(yi)藥(yao)(yao)市場(chang)總銷售(shou)的50%、上市公(gong)司（002581）市值超過(guo)(guo)一萬億；通(tong)(tong)過(guo)(guo)建(jian)立(li)(li)新藥(yao)(yao)高速(su)公(gong)路，未名(ming)醫(yi)藥(yao)(yao)將(jiang)每年獲(huo)得25張新藥(yao)(yao)證書(shu)；通(tong)(tong)過(guo)(guo)國際化的企業(ye)(ye)重組(zu)并購，未名(ming)醫(yi)藥(yao)(yao)成為世界(jie)上較大的醫(yi)藥(yao)(yao)企業(ye)(ye)集團(tuan)。
買購網APP
手機版Maigoo
藥品
